Pattern of matrix metalloproteinases-9, P53 and BCL-2 proteins in egyptian patients with pulmonary mycobacterium tuberculosis

Acta Microbiologica et Immunologica Hungarica

Volumn 57, Issue 2, 2010, Pages 123-133

  El Masry, Samir ^a   Lotfy, Mahmoud ^a   Samy, Mona ^b   Moawia, Shadin ^a   El Sayed, Ibrahim ^a   Khamees, Islam ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

Author keywords

Bcl 2; matrix metalloproteinases; Mycobacterium tuberculosis; P53

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PHYCOERYTHRIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; BACTERIUM CULTURE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EGYPT; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPUTUM CULTURE; THORAX RADIOGRAPHY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77954435515     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.57.2010.2.5     Document Type: Article

References (33)

1. Tufariello, J. M., Chan, J., Flynn, J. L.: Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 3, 578-590 (2003).
2. Means, T. K., Wang, S., Lein, E. et al.: Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163, 3920-3927 (1999).
3. Smith, P. H. A., Jacobs, R. F., Wilson, C. B.: Immunology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J. Pediatrics 131, 1 (1997).
4. Fulton, S. A., Johnsen, J. M., Wolf, S. F. et al.: Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: Role of phagocytosis. Infect immune 64, 2523-2531 (1996).
5. Shapiro, S. D.: Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr. Op. Cell Biol. 10, 602-608 (1998).
6. Baker, A. H., Edwards, D. R., Murphy, G.: Metalloproteinase inhibitors: Biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727 (2002).
7. Zucker, S., Mirza, H., Conner, C. E., Lorenz, A. F., Drews, M. H., Bahou, W. F., Jesty, J.: Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int. J. Cancer 75, 780-786 (1998).
8. Eickelberg, O., Sommerfeld, C. O., Wyser, C., Tamm, M., Reichenberger, F., Bardin, P. G., Soler, M., Roth, M., Perruchoud, A. P.: MMP and TIMP expression pattern in pleural effusions of different origins. Am. J. Respir. Crit. Care Med. 156, 1987-1992 (1997).
9. Gordon, S., Todd, J., Cohn, Z.: In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J. Exp. Med. 139, 1228-1248 (1974).
10. Friedland, J. S., Shaw, T. C., Price, N. M., Dayer, J. M.: Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis. Matrix Biol. 21, 103-110 (2002).
11. Rivera-Marrero, C. A., Schuyler, W., Roser, S., Ritzenthaler, J. D., Newburn, S. A., Roman, J.: Mycobacterium tuberculosis induction of matrix metalloproteinase-9: The role of mannose and receptor-mediated mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol. 282, L546-L555 (2002).
12. Rivera-Marrero, C. A., Schuyler, W., Roser, S., Roman, J.: Induction of MMP-9 mediated gelatinolytic activity in human monocytic cells by cell wall components of Mycobacterium tuberculosis. Microbial Pathogenesis 29, 231-244 (2000).
13. Chang, J. C., Wysocki, A., Tchou-Wong, K. M., Moskovitz, N., Zhang, Y., Rom, W. N.: Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 51, 306-311 (1996).
14. Briken, V., Miller, J. L.: Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis (review). Future Microbiol. 3, 415-422 (2008).
15. World Medical Association (WMA): Declaration of Helsinki; Ethical Principles for Medical Research Involving Human Subjects. 59th WMA General Assembly, Seoul, October 2008.
16. Jenkins, P. A.: The laboratory diagnosis of mycobacterial disease. Common Dis. Respire CDR Rev. 2(9), 101 (1992).
17. Kappelmayer, J., Gratama, J. W., Karaszi, E., Menendez, P., Ciudad, J., Rivas, R., Orfao, A.: Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. interaction between monoclonal antibody clone, fluorochromes and sample preparation protocols. J. Immunol. Methods 242, 53-65 (2000).
18. Massó, F., Paéz, A., Varela, E., Diaz de León, L., Zenteno, E.: Collagen degrading activity associated with Mycobacterium species. Thorax 54, 439-441 (1999).
19. Dannenberg, A. M. Jr.: Roles of cytotoxic delayed-type hypersensitivity and macrophage- activating cell-mediated immunity in the pathogenesis of tuberculosis. Immunobiol. 191, 461-473 (1994).
20. Cataldo, D., Munaut, C., Noel, A., Frankenne, F., Bartsch, P., Foidart, J. M. et al.: MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int. Arch. Allergy Immunol. 123, 259-267 (2000).
21. Fukuda, Y., Ishizaki, M., Kudoh, S., Kitaichi, M., Yamanaka, N.: Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab. Invest. 78, 687-698 (1998).
22. Russell, R. E., Culpitt, S. V., DeMatos, C., Donnelly, L., Smith, M., Wiggins, J. et al.: Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 26, 602-609 (2002).
23. Lanchou, J., Corbel, M., Tanguy, M., Germain, N., Boichot, E., Theret, N. et al.: Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit. Care Med. 31, 536-542 (2003).
24. Jeffrey, J. A., Robert, M. S.: Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 28, 12-24 (2003).
25. Shapiro, S. D.: The macrophage in chronic obstructive pulmonary disease. Am. J. Crit. Care Med. 160, S29-S32 (1999).
26. Hanahan, D., Weinberg, R. A.: The hallmarks of cancer. Cell 100, 57-70 (2000).
27. Briken, V., Porcelli, S. A., Besra, G. S., Kremer, L.: Mycobacterial lipoarabinomannan and related lipoglycans: From biogenesis to modulation of the immune response. Mol. Microbiol. 53, 391-403 (2004).
28. Karakousis, P. C., Bishai, W. R., Dorman, S. E.: Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol. 6, 105-116 (2004).
29. Zhang, J., Jiang, R., Takayama, H., Tanaka, Y.: Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. Microbiol. Immunol. 49, 845-852 (2005).
30. Galietti, F., Bollo, E., Cappia, S., Dondo, A., Pregel, P., Nicali, R., Pozzi, E.: p53 expression in cultured blood human monocytes infected with mycobacterial strains. Panminerva Med. 43, 249-255 (2001).
31. Sly, L. M., Hingley-Wilson, S. M., Reiner, N. E., McMaster, W. R.: Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J. Immunol. 170, 430-437 (2003).
32. Danelishvili, L., McGarvey, J., Li, Y., Bermudez, L. E.: Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol. 5, 649-660 (2003).
33. Perskvist, N., Long, M., Stendahl, O., Zheng, L.: Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway. J. Immunol. 168, 6358-6365 (2002).